A phase I study of toripalimab, an anti‐PD‐1 antibody,...

  • Main
  • 2020 / 06
  • A phase I study of toripalimab, an anti‐PD‐1 antibody,...
Cancer Communications 2020 / 06

A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumors

Wei, Xiao‐Li, Ren, Chao, Wang, Feng‐Hua, Zhang, Yang, Zhao, Hong‐Yun, Zou, Ben‐Yan, Wang, Zhi‐Qiang, Qiu, Miao‐Zhen, Zhang, Dong‐Sheng, Luo, Hui‐Yan, Wang, Feng, Yao, Sheng, Xu, Rui‐
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer Communications
DOI:
10.1002/cac2.12068
Date:
June, 2020
File:
PDF, 482 KB
2020
Conversion to is in progress
Conversion to is failed